Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
102.57
(
-1.79%
)
Bitcoin
70,292.00
(
0.56%
)
News Focus
News Focus
Post# of 30494
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ilpapa post# 2865

Tuesday, 06/14/2011 6:05:36 PM

Tuesday, June 14, 2011 6:05:36 PM

Post# of 30494

IPHS—Getting your arms around such a company would be a daunting task…

It’s not as bad as it sounds, IMO. They have two kinds of products: “value added” branded phosphates and run-of-the-mill generic phosphates. Loosely speaking, the margins are similar to those for branded and generic drugs, respectively.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today